Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
The cannabis clinical scrutiny embraced by industry leaders marks a pivotal shift toward transparency and patient safety. This approach ensures clinicians have reliable data for evidence-based prescribing decisions. Cannabis clinical scrutiny benefits…
Examining CBD Bioavailability Challenges and Precision Claims
CBD bioavailability challenges remain a significant barrier to precision delivery in cannabis therapeutics. Claims of precision CBD delivery require rigorous clinical evidence to ensure dosing consistency. Without peer-reviewed pharmacokinetic data,…
Cannabidiol for Fibromyalgia: Clinical Trial Evidence and Analysis
This cannabidiol clinical trial fibromyalgia study found no superiority of CBD over placebo in reducing pain. The trial highlights the gap between patient use and clinical evidence. Clinicians should guide fibromyalgia patients based on evolving research.
Most-Prescribed Medicinal Cannabis Type ‘Not Supported by Evidence’ | AusDoc
The most prescribed medicinal cannabis type is currently not supported by strong evidence. This update highlights important developments in cannabis medicine. Clinicians should consider this when reviewing treatment options.
How Minor Cannabinoids Like THCV and CBDV Influence the Entourage Effect
Minor cannabinoids clinical relevance is gaining attention as THCV and CBDV appear in more products. Understanding their role in the entourage effect is crucial for clinical guidance. This article reviews current evidence and practical advice for…
New Study Explores Cannabis Effects on Memory and Cognition
Cannabis memory cognitive function is a complex area of research with new studies providing fresh insights. This study examines how acute cannabis use affects memory and cognition. Understanding these effects is crucial for clinical relevance and patient…
Clinics Handing Out Medicinal Cannabis for Anxiety and Depression Despite ‘No Evidence’ It Works
Clinics handing out medicinal cannabis anxiety treatments are increasing despite limited evidence of effectiveness. This trend raises important questions for clinicians and patients alike. Monitoring emerging research is essential for informed clinical…
Cannabis Regulation in Sports – The Cureus Journal of Medical Science
This article covers cannabis regulation sports developments with clinical relevance. It highlights important evidence and policy updates from the Cureus Journal of Medical Science. Clinicians and sports professionals should review this focus area…
Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin
The cannabinoids chronic pain evidence review reveals moderate efficacy signals across several conditions but highlights the low quality of current studies. While cannabinoids show promise, the evidence remains thin due to small sample sizes and short…
Medical Cannabis for Chronic Pain: Promise, Pharmacology, and Persistent Gaps
This 2025 medical cannabis chronic pain review examines the pharmacology and clinical evidence for cannabinoids in pain management. While promising, significant gaps remain in standardized dosing and long-term safety data. The review highlights the need…